Align Technology, Inc. (ALGN) Key Statistics & Metrics

Align Technology, Inc. (ALGN) has an ST Score of 62.2 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Wall Street's consensus rating on ALGN is Buy based on 33 analyst ratings. Our own ST Score grades it B (62.2/100). This is data, not investment advice — always do your own research.

Align Technology, Inc. (ALGN) earns a valuation grade of C-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Align Technology, Inc. (ALGN) earns a growth grade of C-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Align Technology, Inc. (ALGN) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Align Technology, Inc. (ALGN) earns a financial strength grade of B, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for Align Technology, Inc. (ALGN) is $205.25 from 33 analysts, which is +0.3% versus the recent price of $153.29.

Align Technology, Inc. (ALGN) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.